期刊文献+

新合成的生长抑素SOMa对吗啡依赖大鼠的影响 被引量:4

THE EFFECT OF NEWLY SYNTHESIZED SOMATOSTATIN ANALOGS ON MORPHINE-INDUCED DEPENDENCE IN MICE
下载PDF
导出
摘要 目的 :研究自行设计、合成的生长抑素类似物 (SOMa)对吗啡依赖大鼠的影响。方法 :建立大鼠吗啡依赖模型和SOMa模型 ;观察SOMa对大鼠吗啡依赖和吗啡依赖大鼠纳洛酮催促戒断症状的影响及SOMa自身的躯体依赖性。结果 :SOMa能明显降低吗啡依赖大鼠纳洛酮催促戒断症状 ,减轻甚至阻断大鼠吗啡依赖形成 ;大鼠连续使用SOMa 2 1d后纳洛酮催促戒断 ,无明显戒断症状发生。结论 :SOMa具有明显的抑制纳洛酮催促的吗啡依赖戒断反应 ,可降低大鼠对吗啡的依赖性 ;SOMa不产生躯体依赖性。SOMa可作为生物源性的有效脱毒药物进一步研究。 Objective: To investigate the abi li ty of newly synthetic somatostatin analogs to reduce morphine-induced dependence . Methods: Rat morphine dependence model was established. So matostatin analogs were given to observe naloxone precipitated morphine withdraw al symptoms, the influence on morphine induced dependence and the dependence pro ducing potential of somatostatin analogs. Results:A r eduction in the incidence of three main signs of abstinence:wet dog shakes, jumping an d body weight were observed when an acute injection of somatostatin analogs was given just before naloxone administration. No significant physical dependence wa s produced after repeated treatment with somatostatin analogs alone. C onclusion:Somatostatin analogs are able to reduce morphine-induced dep endence and no physical dependence producing potential was observed, which is w orth further study on developing a medicine for detoxification with it.
出处 《中国药物依赖性杂志》 CAS CSCD 2005年第1期16-19,共4页 Chinese Journal of Drug Dependence
基金 国家自然科学基金 (39870 896 )资助项目
关键词 吗啡依赖 大鼠 SOM 纳洛酮 戒断症状 躯体依赖 生长抑素 目的 产生 morphine somatostatin analogs drug dependence withdrawal symptoms
  • 相关文献

参考文献6

  • 1Gulya K, Pelton JT, Hruby VJ, et al. Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors[J]. Life Sci, 1986, 38(24): 2221-2229.
  • 2Bonner GG, Davis P, Stropova D, et al. Opioid peptides:simultaneous delta agonism and mu antagonism in somatostatin analogues[J]. Peptides, 1997, 18(1): 93-100.
  • 3Perez J, Vezzani A, Civenni G, et al. Functional effects of D-phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats[J]. Neuroscience, 1995, 65(4): 1087-1097.
  • 4Cai RZ, Szoke B, Lu R, et al. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin[J]. Proc Natl Acad Sci USA, 1986, 83(6): 1896-1900.
  • 5Peachey JE, Lei H. Assessment of opioid dependence with naloxone[J]. Br J Addict, 1988, 83(2): 193-201.
  • 6Berger V, Alloui A, Kemeny JL, et al. Evidence for a role for bulbospinal pathways in the spinal antinociceptive effect of systemically administered vapreotide in normal rats[J]. Fundam Clin Pharmacol, 1998, 12(2): 200-204.

同被引文献30

  • 1Yong Li Yao~1 Bo Xu~2 Wan Dai Zhang~1 Yu Gang Song~1 ~1Institute of Gastrointestinal Diseases,Nanfang Hospital,First Military Medical University,Guangzhou 510515,Guangdong Province,China ~2Department of Orthopedics Nanfang Hospital,First Military Medical University,Guangzhou 510515,Guangdong Province,ChinaYong Li Yao graduated from First Military Mcdical University with a master degree in 1998.She now works in the Institute of Gastrointestinal Diseases,Nanfang Hospital as a doctoral candidate majoring gastrointestinal diseases and gastrointestinal hormones,she has published 8 papers..Gastrin,somatostatin,and experimental disturbance of the gastrointestinal tract in rats[J].World Journal of Gastroenterology,2001,7(3):399-402. 被引量:12
  • 2Osterbrink J, Haas U. Opioid - induced bowel dysfunction: a literature analysis on pathophysiology and treatment [ J ]. Wien Med Wochenschr, 2008 ( 21 - 22 ) : 621 - 626.
  • 3Holzer P. Treatment of opioid - induced gut dysfunction. Expert Opin Investig Drugs,2007 (2) : 181 - 194.
  • 4Elitok B, Elitok OM, Ketani MA, et al. The effect of dexamethasone on gastric mucosal changes following sialoadenectomy in rat [ KJ ]. J Endocrinol Invest, 2005 ( 8 ) : 700 - 703.
  • 5Sabbatini ME. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system [ J ]. Regul Pept,2009 (1 -3) : 5 -15.
  • 6Stumpf WE, Hayakawa N. Salivary glands epithelial and myoepithelial cells are major vitamin D targets[ J ]. Eur J Drug Metab Pharmacokinet ,2007 (3) : 123 -129.
  • 7Pawlikowski M, Melen- Mueha G. Perspectives of new potential therapeutic applications of somatostatin analogs [J]. Neuro Endocrinol Lett,2003 (1 -2) : 21 -27.
  • 8Hatzoglou A, Kampa M, Castanas E. Opioid - somatostatin interactions in regulating cancer cell growth [ J ]. Front Biosci, 2005 (10) :244 - 256.
  • 9Meerpohl JJ, Timmer A. News from the cochrane library: mu opioid antagonists for opioid - induced bowel dysfunction [ J ] Z Gastroenterol, 2008 ( 9 ) : 917 - 921.
  • 10Guang JS, Xu ZZ, Zhang X, et al. Interaction with vesicle lu- minal protachykinin regulates surface expression of deha-opl- old receptors and opoid analgesla[J]. Cell, 2005,122 (4) : 496- 498.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部